Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stella Pharma Corporation
Nurix Therapeutics, Inc.
TCR2 Therapeutics
Numab Therapeutics AG
NuCana plc
Medicenna Therapeutics, Inc.
Aminex Therapeutics, Inc.
University Hospital, Antwerp
Prelude Therapeutics
Centre Hospitalier Universitaire Vaudois
Multitude Therapeutics Inc.
Mabpro, a.s.
Jules Bordet Institute
Institut Bergonié
Quadriga Biosciences, Inc.
Eli Lilly and Company
Abramson Cancer Center at Penn Medicine
Fox Chase Cancer Center
Kantonsspital Winterthur KSW
Chinese PLA General Hospital
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)